160 Noncontrolling Interests in Consolidated Financial Statements anamendment of ARB No

160, “Noncontrolling Interests in Consolidated Financial Statements, anamendment of ARB No. 51″, which requires that noncontrolling interests,formerly termed minority interests, be considered a component of equity forall periods presented. Noncontrolling interests were previously classified within other long-term liabilities. In measuring performance in controlling thismanaged working capital, we exclude the effects of LIFO inventory valuation reserves, excess and obsolete inventory reserves, and reserves for uncollectibleaccounts receivable which, due to their nature, are managed separately. TORONTO, ONTARIO, Apr 22 (MARKET WIRE) — Bio-Extraction Inc. (TSX VENTURE: BXI) will release its fiscal 2008financial results following the close of markets on April 28, 2009.Management will host a conference call on April 29 at 10:00 a.m (EasternTime) to review the financial results. Live Conference Call: Dial-in Numbers: 416-340-8061 / 866-225-2055 Instant Replay: Dial-in Numbers: 416-695-5800 / 800-408-3053 Passcode: 2552482 Available Until: May 6, 2009 11:59 PM The call will also be audio-cast live and archived for 90 days at.

Saskatoon Plant Update Ramp-up progress continues with ongoing increases in shipments andquantity and quality of both meal, and expeller grade non-GMO oil, inPhase 1 of the operation. This week the plant has moved from 24 houroperation on a 4 day per week basis to now operating on a 24 hour, 7 dayweek per week basis. As production volumes and quality continue to grow,the Company will move closer to its short-term goal of operating on abreak-even or positive cash flow basis at the plant. These efforts aresupported by continued strength in canola crush margins, at or nearlevels not seen since 2004. Equipment for the Phase 2 extraction processhas begun to arrive on site and some of this equipment will be deployedin achieving the full quality and quantity goals for Phase 1 in the nearterm. As the fabrication of the Phase 2 equipment has continued, two of theCompany’s vendors have brought forth recommendations to modify thesolvent recovery equipment to allow for a two-step recovery processrather than the one-step design BioExx has used historically. After muchdebate, the Company has agreed that it would be prudent to pursue thiscourse with the primary benefit being a further mitigation of scale-uprisk for solvent recovery.

There will also be a significant secondarybenefit accruing from added efficiency in protein isolate production byeliminating a drying and re-wetting step that would otherwise occur inthe protein process. Adoption of this plan will result in Phase 2start-up moving to mid-third quarter, but the Company is hopeful thatthis will also offer a faster path to the start-up of Phase 3 proteinproduction. “We continue to be very pleased with the tremendous effort of our entireSaskatoon production and engineering teams and the ongoing success thatthey are having. It is through these efforts that we are able to managedesign improvements such as this without any lasting impact to theschedule and to help us further improve the economics of our core valueproposition, protein production.” said BioExx CEO, Chris Carl About Bio-Extraction Inc.